Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cleveland Cord Blood Center is an FDA-approved, independent public cord blood bank that collects, processes, stores, and distributes umbilical cord blood stem cell units for transplantation in patients with life-threatening disorders such as leukemia, lymphoma, and immune system diseases. It also supports research into new uses of cord blood-derived cells in regenerative medicine and immunotherapy. Through its subsidiary CCTI, it provides clinical-grade materials to partners developing next-generation cell therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cleveland Cord Blood Center.